Association of body mass index with cardiometabolic disease in the UK biobank: A mendelian randomization study

JAMA Cardiology

Volumn 2, Issue 8, 2017, Pages 882-889

  Lyall, Donald M ^a   Celis Morales, Carlos ^a   Ward, Joey ^a   Iliodromiti, Stamatina ^a   Anderson, Jana J ^a   Gill, Jason M R ^a   Smith, Daniel J ^a   Ntuk, Uduakobong Efanga ^a   Mackay, Daniel F ^a   Holmes, Michael V ^b,c,d   Sattar, Naveed ^a   Pell, Jill P ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d NIHR OXFORD BIOMEDICAL RESEARCH CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL;

ADULT; AGE; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MENDELIAN RANDOMIZATION ANALYSIS; METABOLIC DISORDER; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PREVALENCE; PRIORITY JOURNAL; PULSE RATE; SELF REPORT; SEX; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SYSTOLIC BLOOD PRESSURE; UNITED KINGDOM; BIOBANK; BLOOD PRESSURE; CORONARY ARTERY DISEASE; DRINKING BEHAVIOR; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; HEART RATE; MULTIFACTORIAL INHERITANCE; OBESITY; ODDS RATIO; SOCIAL CLASS;

ALCOHOL DRINKING; BIOLOGICAL SPECIMEN BANKS; BLOOD PRESSURE; BODY MASS INDEX; COHORT STUDIES; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HEART RATE; HUMANS; HYPERTENSION; MALE; MENDELIAN RANDOMIZATION ANALYSIS; MIDDLE AGED; MULTIFACTORIAL INHERITANCE; OBESITY; ODDS RATIO; OVERWEIGHT; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; SMOKING; SOCIAL CLASS; STROKE; UNITED KINGDOM;

EID: 85027058334     PISSN: 23806583     EISSN: 23806591     Source Type: Journal    
DOI: 10.1001/jamacardio.2016.5804     Document Type: Article

References (35)

1. De Schutter A, Lavie CJ, Milani RV. The impact of obesity on risk factors and prevalence and prognosis of coronary heart disease-the obesity paradox. Prog Cardiovasc Dis. 2014;56(4):401-408.
2. World Health Organization. Obesity and overweight. http://www. who. int/mediacentre /factsheets/fs311/en/. Updated June 2016. Accessed May 12, 2016.
3. Hall ME, do Carmo JM, da Silva AA, Juncos LA, Wang Z, Hall JE. Obesity, hypertension, and chronic kidney disease. Int J Nephrol Renovasc Dis. 2014;7: 75-88.
4. Eckel RH, Kahn SE, Ferrannini E, et al; Endocrine Society; American Diabetes Association; European Association for the Study of Diabetes. Obesity and type 2 diabetes: what can be unified and what needs to be individualized Diabetes Care. 2011;34 (6):1424-1430.
5. Lu Y, Hajifathalian K, Ezzati M, Woodward M, Rimm EB, Danaei G; Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration (BMI Mediated Effects). Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: A pooled analysis of 97 prospective cohorts with 18 million participants. Lancet. 2014;383(9921):970-983.
6. Benito-Leon J, Mitchell AJ, Hernandez-Gallego J, Bermejo-Pareja F. Obesity and impaired cognitive functioning in the elderly: A population-based cross-sectional study (NEDICES). Eur J Neurol. 2013;20(6):899-906, e76-e77.
7. Yang J, Manolio TA, Pasquale LR, et al. Genome partitioning of genetic variation for complex traits using common SNPs. Nat Genet. 2011;43(6):519-525.
8. Davey Smith G, Hemani G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Genet. 2014; 23(R1):R89-R98.
9. Smith GD, Ebrahim S. Mendelian randomization: can genetic epidemiology contribute to understanding environmental determinants of disease Int J Epidemiol. 2003;32(1):1-22.
10. Nordestgaard BG, Palmer TM, Benn M, et al. The effect of elevated body mass index on ischemic heart disease risk: causal estimates from a mendelian randomisation approach. PLoS Med. 2012;9(5):e1001212.
11. HolmesMV, Lange LA, Palmer T, et al. Causal effects of body mass index on cardiometabolic traits and events: A mendelian randomization analysis. Am J Hum Genet. 2014;94(2):198-208.
12. Hagg S, Fall T, Ploner A, et al; European Network for Genetic and Genomic Epidemiology Consortium. Adiposity as a cause of cardiovascular disease: A mendelian randomization study. Int J Epidemiol. 2015;44(2):578-586.
13. Locke AE, Kahali B, Berndt SI, et al; LifeLines Cohort Study; ADIPOGen Consortium; AGEN-BMI Working Group; CARDIOGRAMplusC4D Consortium; CKDGen Consortium; GLGC; ICBP; MAGIC Investigators; MuTHER Consortium; MIGen Consortium; PAGE Consortium; ReproGen Consortium; GENIE Consortium; International Endogene Consortium. Genetic studies of body mass index yield new insights for obesity biology. Nature. 2015;518(7538):197-206.
14. Bohm M, Reil J-C, Deedwania P, Kim JB, Borer JS. Resting heart rate: risk indicator and emerging risk factor in cardiovascular disease. Am J Med. 2015;128(3):219-228.
15. Sudlow C, Gallacher J, Allen N, et al. UK Biobank: An open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12(3):e1001779.
16. Allen N, Sudlow C, Downey P, et al. UK Biobank: current status and what it means for epidemiology. Health Policy Technol. 2012;1:123-126.
17. Bhatnagar P, Scarborough P, Smeeton NC, Allender S. The incidence of all stroke and stroke subtype in the United Kingdom, 1985 to 2008: A systematic review. BMC Public Health. 2010;10:539.
18. Celis-Morales CA, Perez-Bravo F, Ibanez L, Salas C, Bailey MES, Gill JMR. Objective vs. self-reported physical activity and sedentary time: effects of measurement method on relationships with risk biomarkers. PLoS One. 2012;7(5):e36345.
19. Townsend P. Deprivation. J Soc Policy. 1987;16(2): 125-146.
20. Genotyping and quality control of UK Biobank, a large-scale, extensive phenotyped prospective resource. US Biobank. http://www. ukbiobank. Ac. uk /wp-content/uploads/2014/04/UKBiobank -genotyping-QC-documentation-web. pdf. Published 2015. Accessed January 31, 2017.
21. Rodriguez S, Gaunt TR, Day INM. Hardy-Weinberg equilibrium testing of biological ascertainment for mendelian randomization studies. Am J Epidemiol. 2009;169(4):505-514.
22. StataCorp. Stata Statistical Software: Release 13. College Station, TX: StataCorp Inc; 2013.
23. Purcell S, Neale B, Todd-Brown K, et al. PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81(3):559-575.
24. Williams SM, Haines JL. Correcting away the hidden heritability. AnnHumGenet. 2011;75(3):348-350.
25. Baum CF, Schaffer ME, Stillman S. IVREG2: Stata module for extended instrumental variables/2SLS and GMM estimation. http://ideas. repec. org/c/boc/bocode/s425401. html. Published 2016. Accessed February 11, 2016.
26. Burgess S, Thompson SG; CRP CHD Genetics Collaboration. Avoiding bias from weak instruments in mendelian randomization studies. Int J Epidemiol. 2011;40(3):755-764.
27. Palmer TM, Sterne JAC, Harbord RM, et al. Instrumental variable estimation of causal risk ratios and causal odds ratios in mendelian randomization analyses. Am J Epidemiol. 2011;173(12):1392-1403.
28. White J, Swerdlow DI, Preiss D, et al. Association of lipid fractions with risks for coronary artery diseaseanddiabetes. JAMACardiol. 2016;1(6):692-699.
29. Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44(2):512-525.
30. Fall T, Hagg S, Magi R, et al; European Network for Genetic and Genomic Epidemiology (ENGAGE) Consortium. The role of adiposity in cardiometabolic traits: A mendelian randomization analysis. PLoS Med. 2013;10(6):e1001474.
31. Timpson NJ, Harbord R, Davey Smith G, Zacho J, Tybjaerg-Hansen A, Nordestgaard BG. Does greater adiposity increase blood pressure and hypertension risk mendelian randomization using the FTO/ MC4Rgenotype. Hypertension. 2009;54(1):84-90.
32. Lyall DM, Cullen B, Allerhand M, et al. Cognitive test scores in UK Biobank: data reduction in 480, 416 participants and longitudinal stability in 20, 346 participants. PLoS One. 2016;11(4):e0154222.
33. Collins R. What makes UK Biobank special Lancet. 2012;379(9822):1173-1174.
34. Bhatnagar P, Wickramasinghe K, Williams J, Rayner M, Townsend N. The epidemiology of cardiovascular disease in the UK 2014. Heart. 2015; 101(15):1182-1189.
35. National Health Service. Health survey for England, 2014: Trend tables. http://content. digital. nhs. uk/catalogue/PUB19297. Published December 16, 2015. Accessed September 7, 2016.